Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xyrem in Fibromyalgia
NCT00087555Phase 2Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Jul 2004
- Primary completion
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium oxybate in fibromyalgia (FM), sponsored by Jazz Pharmaceuticals plc. Started Jul 2004; status: completed.
02
Drugs
sodium oxybate
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT00087555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00087555.